Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Sun

Showing results (61-70 of 105) with videos related to

Pageof 11
Sort By:
JCO Precision Oncology|July 16, 2025
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TTAndrew J Pellatt, Alisha Bent, Nicholas Hornstein, et al.
Cancer Research Communications|May 6, 2024
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal AdenocarcinomaNicholas J Hornstein, Mohammad A Zeineddine, Betul B Gunes, et al.
Oncology|July 19, 2023
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular CarcinomaShadi Chamseddine, Yehia I Mohamed, Sunyoung S Lee, et al.
Journal of Immunotherapy and Precision Oncology|November 11, 2024
Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular CarcinomaShadi Chamseddine, Betul Gok Yavuz, Yehia I Mohamed, et al.
Annals of Surgical Oncology|December 10, 2025
Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II TrialIan W Folkert, Reza Mehran, Ryan Sun, et al.
Blood Immunology & Cellular Therapy|July 8, 2026
Identification of an optimal absolute lymphocyte count at leukapheresis in patients with lymphoma treated with CARTKunhwa Kim, Zachary Hunzeker, Xiaowen Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2024
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial MisinterpretationTimothy A Lin, Zachary R McCaw, Alex Koong, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information systemRyan Sun, Rodney H Breau, Ranjeeta Mallick, et al.
Haematologica|November 30, 2023
Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapyAndrew P Jallouk, Naishu Kui, Ryan Sun, et al.
NPJ Precision Oncology|February 13, 2023
Survival improvement for patients with metastatic colorectal cancer over twenty yearsFadl A Zeineddine, Mohammad A Zeineddine, Abdelrahman Yousef, et al.
Pageof 11

Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
JCO Precision Oncology|July 16, 2025
Phase II Trial of TAS-102 in Colorectal Cancer Patients With Circulating Tumor DNA-Defined Minimal Residual Disease After Adjuvant Therapy: INTERCEPT-TTAndrew J Pellatt, Alisha Bent, Nicholas Hornstein, et al.
Cancer Research Communications|May 6, 2024
Efficacy and Safety of Atezolizumab and Bevacizumab in Appendiceal AdenocarcinomaNicholas J Hornstein, Mohammad A Zeineddine, Betul B Gunes, et al.
Oncology|July 19, 2023
Clinical and Prognostic Biomarker Value of Blood-Circulating Inflammatory Cytokines in Hepatocellular CarcinomaShadi Chamseddine, Yehia I Mohamed, Sunyoung S Lee, et al.
Journal of Immunotherapy and Precision Oncology|November 11, 2024
Circulating Galectin-3: A Prognostic Biomarker in Hepatocellular CarcinomaShadi Chamseddine, Betul Gok Yavuz, Yehia I Mohamed, et al.
Annals of Surgical Oncology|December 10, 2025
Hepatectomy Plus Chemotherapy or Chemotherapy Alone for Resectable Liver and Unresectable Lung Metastases from Colorectal Adenocarcinoma (LUNA): A Randomized Phase II TrialIan W Folkert, Reza Mehran, Ryan Sun, et al.
Blood Immunology & Cellular Therapy|July 8, 2026
Identification of an optimal absolute lymphocyte count at leukapheresis in patients with lymphoma treated with CARTKunhwa Kim, Zachary Hunzeker, Xiaowen Sun, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 12, 2024
Proportional Hazards Violations in Phase III Cancer Clinical Trials: A Potential Source of Trial MisinterpretationTimothy A Lin, Zachary R McCaw, Alex Koong, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|October 2, 2020
Prognostic impact of paraneoplastic syndromes on patients with non-metastatic renal cell carcinoma undergoing surgery: Results from Canadian Kidney Cancer information systemRyan Sun, Rodney H Breau, Ranjeeta Mallick, et al.
Haematologica|November 30, 2023
Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapyAndrew P Jallouk, Naishu Kui, Ryan Sun, et al.
NPJ Precision Oncology|February 13, 2023
Survival improvement for patients with metastatic colorectal cancer over twenty yearsFadl A Zeineddine, Mohammad A Zeineddine, Abdelrahman Yousef, et al.
Pageof 11